5.62
price up icon0.18%   0.010
 
loading
Pulmatrix Inc stock is traded at $5.62, with a volume of 6,560. It is up +0.18% in the last 24 hours and down -17.84% over the past month. Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
See More
Previous Close:
$5.61
Open:
$5.61
24h Volume:
6,560
Relative Volume:
0.23
Market Cap:
$20.53M
Revenue:
$11.68M
Net Income/Loss:
$-8.85M
P/E Ratio:
-2.332
EPS:
-2.41
Net Cash Flow:
$-14.61M
1W Performance:
-9.50%
1M Performance:
-17.84%
6M Performance:
-22.80%
1Y Performance:
+166.35%
1-Day Range:
Value
$5.61
$5.80
1-Week Range:
Value
$5.60
$6.30
52-Week Range:
Value
$1.78
$10.40

Pulmatrix Inc Stock (PULM) Company Profile

Name
Name
Pulmatrix Inc
Name
Phone
(888) 355-4440
Name
Address
945 CONCORD STREET, FRAMINGHAM, MA
Name
Employee
2
Name
Twitter
@pulmatrix_inc
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
PULM's Discussions on Twitter

Compare PULM with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
PULM
Pulmatrix Inc
5.62 20.49M 11.68M -8.85M -14.61M -2.41
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Pulmatrix Inc Stock (PULM) Upgrades & Downgrades

Date Action Analyst Rating Change
Feb-09-18 Initiated H.C. Wainwright Buy

Pulmatrix Inc Stock (PULM) Latest News

pulisher
Jul 25, 2025

Pulmatrix Inc. Stock Analysis and ForecastTremendous growth potential - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Is Pulmatrix Inc. a good long term investmentOverwhelming financial success - Autocar Professional

Jul 25, 2025
pulisher
Jul 24, 2025

What makes Pulmatrix Inc. stock price move sharplyFree Real-Time Trading Opportunities - Newser

Jul 24, 2025
pulisher
Jul 23, 2025

What drives Pulmatrix Inc. stock priceTremendous growth potential - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Pulmatrix Inc. stockExtraordinary profit generation - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

What analysts say about Pulmatrix Inc. stock outlookCapital Preservation Investment Ideas - Newser

Jul 22, 2025
pulisher
Jul 22, 2025

Long Term Trading Analysis for (PULM) - news.stocktradersdaily.com

Jul 22, 2025
pulisher
Jul 22, 2025

Reviewing Pulmatrix (NASDAQ:PULM) and Vanda Pharmaceuticals (NASDAQ:VNDA) - Defense World

Jul 22, 2025
pulisher
Jul 18, 2025

How high can Pulmatrix Inc. stock price go in 2025High Yield Opportunities - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

Why Pulmatrix Inc. stock attracts strong analyst attentionFree Investment Portfolio Suggestions - beatles.ru

Jul 18, 2025
pulisher
Jul 15, 2025

How Pulmatrix Inc. stock performs during market volatilityFree Access to Community with 300% Return - Newser

Jul 15, 2025
pulisher
Jul 01, 2025

(PULM) Technical Data - news.stocktradersdaily.com

Jul 01, 2025
pulisher
Jun 25, 2025

PULM Trading Resumes: Pulmatrix Updates Investors | PULM Stock News - GuruFocus

Jun 25, 2025
pulisher
Jun 25, 2025

Pulmatrix (PULM) Trading Halted Due to Volatility | PULM Stock News - GuruFocus

Jun 25, 2025
pulisher
Jun 23, 2025

Pulmatrix (PULM) Trading Resumes as Investors Watch Closely | PULM Stock News - GuruFocus

Jun 23, 2025
pulisher
Jun 23, 2025

PULM Trading Temporarily Halted Due to Volatility | PULM Stock News - GuruFocus

Jun 23, 2025
pulisher
Jun 23, 2025

PULM Trading Temporarily Halted Due to Volatility | PULM Stock N - GuruFocus

Jun 23, 2025
pulisher
Jun 20, 2025

How to Take Advantage of moves in (PULM) - news.stocktradersdaily.com

Jun 20, 2025
pulisher
Jun 10, 2025

Learn to Evaluate (PULM) using the Charts - news.stocktradersdaily.com

Jun 10, 2025
pulisher
May 21, 2025

Financial Comparison: Pulmatrix (NASDAQ:PULM) & Acelyrin (NASDAQ:SLRN) - Defense World

May 21, 2025
pulisher
May 20, 2025

Pulmatrix (NASDAQ:PULM) Now Covered by StockNews.com - Defense World

May 20, 2025
pulisher
May 18, 2025

(PULM) Trading Advice - news.stocktradersdaily.com

May 18, 2025
pulisher
May 15, 2025

Pulmatrix set for merger with Cullgen, seeks asset divestment By Investing.com - Investing.com South Africa

May 15, 2025
pulisher
May 15, 2025

Enliven stops work on solid tumor drug; Pulmatrix to divest assets - Endpoints News

May 15, 2025
pulisher
May 15, 2025

Pulmatrix Announces Divestment Plan for Assets - citybiz

May 15, 2025
pulisher
May 15, 2025

Pulmatrix Announces First Quarter 2025 Financial Results and Div - GuruFocus

May 15, 2025

Pulmatrix Inc Stock (PULM) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Cap:     |  Volume (24h):